NCT01829971 A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection Status TERMINATED Phase PHASE1
NCT01827111 Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT01820364 LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma Status TERMINATED Phase PHASE2
NCT01813214 The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma Status TERMINATED Phase PHASE2
NCT01785316 The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases Status COMPLETED Phase PHASE3
NCT01783431 Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells Status TERMINATED Phase PHASE1
NCT01782508 A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma Status UNKNOWN Phase PHASE2
NCT01781026 Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases Status COMPLETED Phase PHASE2
NCT01777802 Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy Status COMPLETED Phase N/A
NCT01772771 Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program Status RECRUITING Phase N/A
NCT01770002 Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? Status COMPLETED Phase NA
NCT01764009 Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01760499 Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study Status COMPLETED Phase PHASE1
NCT01754376 Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma Status TERMINATED Phase PHASE2